Lahore Medical and Dental college Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2017
NCT04650763
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CMH Lahore Medical And Dental College | Federal Post-Graduate Medical Institute, Lahore | Lahore Medical and Dental college | Lahore Medical & Dental College | Postgraduate Medical Institute, Lahore

Active Ingredients

Drugs in Phase 4 Trials (1)

simvastatin (zocor) (1 trial)

Drugs in Phase 3 Trials (2)

honey (2 trials)

nigella sativa (1 trial)

Drugs in Other Trials (1)

platelet-rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Infections (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4